The invention described herein provides a method for the treatment of an oestrogen receptor positive breast cancer in a subject in need thereof comprising administering to said subject a therapeutically effective amount of an MPS1 inhibitor, wherein : (i) said subject has previously been treated with an endocrine therapy; and/or (ii) said breast cancer is resistant to endocrine therapy.